Skip to Main Content

The Office of the Attorney General for the District of Columbia is investigating DaVita, one of the largest dialysis providers in the country, and its ties to the nonprofit American Kidney Fund.

DaVita disclosed the new “civil investigative demand” in its latest annual financial filing to investors. The D.C. attorney general is specifically looking at “communications with AKF, documents relating to donations to the AKF, and communications with patients, providers, and insurers regarding the AKF.” The probe covers everything from January 2016 to the present day. DaVita’s competitor, Fresenius, similarly disclosed it received a subpoena from the D.C. attorney general’s office.

advertisement

DaVita said in the filing it “is cooperating with the government in this investigation.” A DaVita spokesperson added in a statement that the D.C. attorney general’s subpoena “focuses on the handful of clinics within D.C. We aim to obtain a swift resolution of this inquiry into a relationship that was previously investigated by the Department of Justice and found to be compliant with the law.”

STAT+ Exclusive Story

STAT+

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

Already have an account? Log in

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe

STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect

To submit a correction request, please visit our Contact Us page.